Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis

被引:0
作者
Tarinee Rungjirajittranon
Weerapat Owattanapanich
Yingyong Chinthammitr
Theera Ruchutrakool
Bundarika Suwanawiboon
机构
[1] Mahidol University,Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital
来源
Thrombosis Journal | / 20卷
关键词
Acute treatment; Direct oral anticoagulants; Gastrointestinal cancer; Low-molecular-weight heparin; Patients; Venous thromboembolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 160 条
[1]  
Mulder FI(2021)Venous thromboembolism in cancer patients: a population-based cohort study Blood 137 1959-1969
[2]  
Horváth-Puhó E(2007)Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 632-634
[3]  
van Es N(2013)Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases Eur J Cancer 49 1404-1413
[4]  
van Laarhoven HWM(2019)The Epidemiology of cancer-associated venous thromboembolism: An update Semin Thromb Hemost 45 321-325
[5]  
Pedersen L(2017)Bidirectional risk between venous thromboembolism and cancer in East Asian patients: synthesis of evidence from recent population-based epidemiological studies Cancer Manag Res 9 751-759
[6]  
Moik F(2020)Gastric Cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies Int J Mol Sci 21 11-9149
[7]  
Khorana AA(2007)Incidence and significance of thromboembolic events (TE) in patients with gastrointestinal (GI) and non-GI malignancies on systemic cytotoxic therapy J Clin Oncol 25 9049-1881
[8]  
Francis CW(2010)High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients J Thromb Haemost 8 1879-624
[9]  
Culakova E(2018)Edoxaban for the treatment of cancer-associated venous thromboembolism N Engl J Med 378 615-2023
[10]  
Kuderer NM(2018)Comparison of an oral factor xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D) J Clin Oncol 36 2017-421